Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Equal palliative care for patients with COPD? A nationwide register study.

Henoch I, Strang P, Löfdahl CG, Ekberg-Jansson A.

Ups J Med Sci. 2019 Apr;124(2):140-147. doi: 10.1080/03009734.2019.1586803. Epub 2019 Apr 23.

2.

Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking.

Kraen M, Frantz S, Nihlén U, Engström G, Löfdahl CG, Wollmer P, Dencker M.

PLoS One. 2019 Feb 21;14(2):e0211987. doi: 10.1371/journal.pone.0211987. eCollection 2019.

3.

Influences of patient education on exacerbations and hospital admissions in patients with COPD - a longitudinal national register study.

Henoch I, Löfdahl CG, Ekberg-Jansson A.

Eur Clin Respir J. 2018 Jul 31;5(1):1500073. doi: 10.1080/20018525.2018.1500073. eCollection 2018.

4.

VEGF synthesis is induced by prostacyclin and TGF-β in distal lung fibroblasts from COPD patients and control subjects: Implications for pulmonary vascular remodelling.

Westergren-Thorsson G, Bagher M, Andersson-Sjöland A, Thiman L, Löfdahl CG, Hallgren O, Bjermer L, Larsson-Callerfelt AK.

Respirology. 2018 Jan;23(1):68-75. doi: 10.1111/resp.13142. Epub 2017 Aug 22.

PMID:
28834088
5.

Characterization of secondary care for COPD in Sweden.

Sundh J, Janson C, Johansson G, Lindén A, Löfdahl CG, Sandström T, Larsson K.

Eur Clin Respir J. 2017 Jan 24;4(1):1270079. doi: 10.1080/20018525.2016.1270079. eCollection 2017.

6.

Brain natriuretic peptide levels in middle aged subjects with normal left ventricular function in relation to mild-moderate COPD.

Kraen M, Frantz S, Nihlén U, Engström G, Löfdahl CG, Wollmer P, Dencker M.

Clin Respir J. 2018 Mar;12(3):1061-1067. doi: 10.1111/crj.12628. Epub 2017 Apr 17.

PMID:
28294547
7.

Management of COPD, equal treatment across age, gender, and social situation? A register study.

Henoch I, Strang S, Löfdahl CG, Ekberg-Jansson A.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 26;11:2681-2690. eCollection 2016.

8.

Echocardiographic consequences of smoking status in middle-aged subjects.

Kraen M, Frantz S, Nihlén U, Engström G, Löfdahl CG, Wollmer P, Dencker M.

Echocardiography. 2017 Jan;34(1):14-19. doi: 10.1111/echo.13375. Epub 2016 Sep 29.

PMID:
27681781
9.

Individualized prediction of lung-function decline in chronic obstructive pulmonary disease.

Zafari Z, Sin DD, Postma DS, Löfdahl CG, Vonk J, Bryan S, Lam S, Tammemagi CM, Khakban R, Man SFP, Tashkin D, Wise RA, Connett JE, McManus B, Ng R, Hollander Z, Sadatsafavi M.

CMAJ. 2016 Oct 4;188(14):1004-1011. doi: 10.1503/cmaj.151483. Epub 2016 Aug 2.

10.

Health-related quality of life in a nationwide cohort of patients with COPD related to other characteristics.

Henoch I, Strang S, Löfdahl CG, Ekberg-Jansson A.

Eur Clin Respir J. 2016 May 27;3:31459. doi: 10.3402/ecrj.v3.31459. eCollection 2016.

11.

The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS).

Miravitlles M, Worth H, Soler-Cataluña JJ, Price D, De Benedetto F, Roche N, Godtfredsen NS, van der Molen T, Löfdahl CG, Padullés L, Ribera A.

COPD. 2016 Oct;13(5):561-8. doi: 10.3109/15412555.2016.1150447. Epub 2016 Mar 16.

PMID:
26983349
12.

The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.

Sundh J, Johansson G, Larsson K, Lindén A, Löfdahl CG, Sandström T, Janson C.

Int J Chron Obstruct Pulmon Dis. 2015 Oct 28;10:2327-34. doi: 10.2147/COPD.S91362. eCollection 2015.

13.

Fixed ratio or lower limit of normal for the FEV1 /VC ratio: relation to symptoms and extended lung function tests.

Wollmer P, Frantz S, Engström G, Dencker M, Löfdahl CG, Nihlén U.

Clin Physiol Funct Imaging. 2017 May;37(3):263-269. doi: 10.1111/cpf.12294. Epub 2015 Oct 6.

PMID:
26443700
14.

The Swedish CArdioPulmonary BioImage Study: objectives and design.

Bergström G, Berglund G, Blomberg A, Brandberg J, Engström G, Engvall J, Eriksson M, de Faire U, Flinck A, Hansson MG, Hedblad B, Hjelmgren O, Janson C, Jernberg T, Johnsson Å, Johansson L, Lind L, Löfdahl CG, Melander O, Östgren CJ, Persson A, Persson M, Sandström A, Schmidt C, Söderberg S, Sundström J, Toren K, Waldenström A, Wedel H, Vikgren J, Fagerberg B, Rosengren A.

J Intern Med. 2015 Dec;278(6):645-59. doi: 10.1111/joim.12384. Epub 2015 Jun 19.

15.

Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units.

Sundh J, Johansson G, Larsson K, Lindén A, Löfdahl CG, Janson C, Sandström T.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 22;10:173-83. doi: 10.2147/COPD.S74645. eCollection 2015.

16.

Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.

Miravitlles M, Worth H, Soler Cataluña JJ, Price D, De Benedetto F, Roche N, Godtfredsen NS, van der Molen T, Löfdahl CG, Padullés L, Ribera A.

Respir Res. 2014 Oct 21;15:122. doi: 10.1186/s12931-014-0122-1.

17.

Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study.

Inghammar M, Engström G, Ljungberg B, Löfdahl CG, Roth A, Egesten A.

BMC Infect Dis. 2014 Mar 25;14:163. doi: 10.1186/1471-2334-14-163.

18.

Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials.

Dong YH, Chang CH, Wu FL, Shen LJ, Calverley PMA, Löfdahl CG, Lai MS, Mahler DA.

Chest. 2014 Jun;145(6):1286-1297. doi: 10.1378/chest.13-2137. Review.

PMID:
24504044
19.

Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD.

Mori M, Andersson CK, Graham GJ, Löfdahl CG, Erjefält JS.

Respir Res. 2013 Jun 11;14:65. doi: 10.1186/1465-9921-14-65.

20.

Invasive pneumococcal disease in patients with an underlying pulmonary disorder.

Inghammar M, Engström G, Kahlmeter G, Ljungberg B, Löfdahl CG, Egesten A.

Clin Microbiol Infect. 2013 Dec;19(12):1148-54. doi: 10.1111/1469-0691.12182. Epub 2013 Mar 7.

21.

Appearance of remodelled and dendritic cell-rich alveolar-lymphoid interfaces provides a structural basis for increased alveolar antigen uptake in chronic obstructive pulmonary disease.

Mori M, Andersson CK, Svedberg KA, Glader P, Bergqvist A, Shikhagaie M, Löfdahl CG, Erjefält JS.

Thorax. 2013 Jun;68(6):521-31. doi: 10.1136/thoraxjnl-2012-202879. Epub 2013 Feb 14.

PMID:
23412435
22.

Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts.

Larsson-Callerfelt AK, Hallgren O, Andersson-Sjöland A, Thiman L, Björklund J, Kron J, Nihlberg K, Bjermer L, Löfdahl CG, Westergren-Thorsson G.

Respir Res. 2013 Feb 14;14:21. doi: 10.1186/1465-9921-14-21.

23.

Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study.

Fattahi F, ten Hacken NH, Löfdahl CG, Hylkema MN, Timens W, Postma DS, Vonk JM.

Respir Res. 2013 Jan 28;14:10. doi: 10.1186/1465-9921-14-10.

24.

BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study.

Lindberg U, Carlsson M, Löfdahl CG, Segelmark M.

Clin Dev Immunol. 2012;2012:370107. doi: 10.1155/2012/370107. Epub 2012 Dec 30.

25.

Validation of a COPD diagnosis from the Swedish Inpatient Registry.

Inghammar M, Engström G, Löfdahl CG, Egesten A.

Scand J Public Health. 2012 Dec;40(8):773-6. doi: 10.1177/1403494812463172. Epub 2012 Oct 19.

PMID:
23085721
26.

Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients.

Hallgren O, Rolandsson S, Andersson-Sjöland A, Nihlberg K, Wieslander E, Kvist-Reimer M, Dahlbäck M, Eriksson L, Bjermer L, Erjefält JS, Löfdahl CG, Westergren-Thorsson G.

J Transl Med. 2012 Aug 22;10:171. doi: 10.1186/1479-5876-10-171.

27.

Impulse oscillometry may be of value in detecting early manifestations of COPD.

Frantz S, Nihlén U, Dencker M, Engström G, Löfdahl CG, Wollmer P.

Respir Med. 2012 Aug;106(8):1116-23. doi: 10.1016/j.rmed.2012.04.010. Epub 2012 May 20.

28.

Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods.

Frantz S, Nihlén U, Dencker M, Engström G, Löfdahl CG, Wollmer P.

Clin Physiol Funct Imaging. 2012 Mar;32(2):120-5. doi: 10.1111/j.1475-097X.2011.01065.x. Epub 2011 Nov 10.

PMID:
22296632
29.

[How the care of COPD will be better].

Larsson K, Löfdahl CG, Lindén A, Sandström T, Johansson GS.

Lakartidningen. 2011 Aug 31-Sep 6;108(35):1604-5. Swedish. No abstract available.

PMID:
22043614
30.

Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.

Andersson CK, Andersson-Sjöland A, Mori M, Hallgren O, Pardo A, Eriksson L, Bjermer L, Löfdahl CG, Selman M, Westergren-Thorsson G, Erjefält JS.

Respir Res. 2011 Oct 20;12:139. doi: 10.1186/1465-9921-12-139.

31.

Impaired pulmonary function and the risk of tuberculosis: a population-based cohort study.

Inghammar M, Löfdahl CG, Winqvist N, Ljungberg B, Egesten A, Engström G.

Eur Respir J. 2011 May;37(5):1285-7. doi: 10.1183/09031936.00091110. No abstract available.

32.

Altered fibroblast proteoglycan production in COPD.

Hallgren O, Nihlberg K, Dahlbäck M, Bjermer L, Eriksson LT, Erjefält JS, Löfdahl CG, Westergren-Thorsson G.

Respir Res. 2010 May 11;11:55. doi: 10.1186/1465-9921-11-55.

33.

COPD and the risk of tuberculosis--a population-based cohort study.

Inghammar M, Ekbom A, Engström G, Ljungberg B, Romanus V, Löfdahl CG, Egesten A.

PLoS One. 2010 Apr 13;5(4):e10138. doi: 10.1371/journal.pone.0010138.

34.

COPD health care in Sweden - A study in primary and secondary care.

Löfdahl CG, Tilling B, Ekström T, Jörgensen L, Johansson G, Larsson K.

Respir Med. 2010 Mar;104(3):404-11. doi: 10.1016/j.rmed.2009.10.007. Epub 2009 Dec 5.

35.

Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease.

Andersson CK, Mori M, Bjermer L, Löfdahl CG, Erjefält JS.

Am J Respir Crit Care Med. 2010 Feb 1;181(3):206-17. doi: 10.1164/rccm.200906-0932OC. Epub 2009 Nov 19.

PMID:
19926870
36.

Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure.

Düringer C, Grundström G, Gürcan E, Dainty IA, Lawson M, Korn SH, Jerre A, Håkansson HF, Wieslander E, Fredriksson K, Sköld CM, Löfdahl M, Löfdahl CG, Nicholls DJ, Silberstein DS.

Br J Pharmacol. 2009 Sep;158(1):169-79. doi: 10.1111/j.1476-5381.2009.00262.x. Epub 2009 Jun 22.

37.

Novel site-specific mast cell subpopulations in the human lung.

Andersson CK, Mori M, Bjermer L, Löfdahl CG, Erjefält JS.

Thorax. 2009 Apr;64(4):297-305. doi: 10.1136/thx.2008.101683. Epub 2009 Jan 8.

PMID:
19131451
38.

Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study.

Engström G, Segelstorm N, Ekberg-Aronsson M, Nilsson PM, Lindgärde F, Löfdahl CG.

Thorax. 2009 Mar;64(3):211-5. doi: 10.1136/thx.2008.102079. Epub 2008 Nov 6.

PMID:
18988660
39.

COPD and co-morbidities, with special emphasis on cardiovascular conditions.

Löfdahl CG.

Clin Respir J. 2008 Oct;2 Suppl 1:59-63. doi: 10.1111/j.1752-699X.2008.00085.x. Review.

PMID:
20298351
40.

A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.

Ställberg B, Ekström T, Neij F, Olsson P, Skoogh BE, Wennergren G, Löfdahl CG; SHARE trial group.

Respir Med. 2008 Oct;102(10):1360-70. doi: 10.1016/j.rmed.2008.06.017. Epub 2008 Aug 23.

41.

Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study.

Egesten A, Brandt L, Olsson T, Granath F, Inghammar M, Löfdahl CG, Ekbom A.

Lung. 2008 May-Jun;186(3):173-178. doi: 10.1007/s00408-008-9081-y. Epub 2008 Mar 20.

PMID:
18351419
42.

Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD.

Nihlén U, Montnémery P, Andersson M, Persson CG, Nyberg P, Löfdahl CG, Greiff L.

Clin Physiol Funct Imaging. 2008 Jul;28(4):240-50. doi: 10.1111/j.1475-097X.2008.00800.x. Epub 2008 Jul 1.

PMID:
18331572
43.

Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD.

Ekbom A, Brandt L, Granath F, Löfdahl CG, Egesten A.

Lung. 2008 May-Jun;186(3):167-172. doi: 10.1007/s00408-008-9080-z. Epub 2008 Mar 11.

PMID:
18330638
44.
45.

[The COPD national guidelines do have a future].

Larsson SA, Löfdahl CG.

Lakartidningen. 2007 Jun 13-26;104(24-25):1891. Swedish. No abstract available.

PMID:
17674667
46.

Mortality risks among heavy-smokers with special reference to women: a long-term follow-up of an urban population.

Ekberg-Aronsson M, Nilsson PM, Nilsson JA, Löfdahl CG, Löfdahl K.

Eur J Epidemiol. 2007;22(5):301-9. Epub 2007 May 30.

PMID:
17534729
47.

[COPD--a multifactorial systemic disease].

Larsson SA, Löfdahl CG.

Lakartidningen. 2007 Mar 28-Apr 3;104(13):1028-31. Review. Swedish. No abstract available.

PMID:
17476903
48.

Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma.

O'Connor BJ, Löfdahl CG, Balter M, Szczeklik A, Boulet LP, Cairns CB.

Respir Med. 2007 Jun;101(6):1088-96. Epub 2007 Mar 13.

49.

Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.

Löfdahl CG, Postma DS, Pride NB, Boe J, Thorén A.

Eur Respir J. 2007 Jun;29(6):1115-9. Epub 2007 Mar 1.

50.

Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers.

Plymoth A, Löfdahl CG, Ekberg-Jansson A, Dahlbäck M, Broberg P, Foster M, Fehniger TE, Marko-Varga G.

Clin Chem. 2007 Apr;53(4):636-44. Epub 2007 Feb 15.

Supplemental Content

Loading ...
Support Center